Travelan has a whole lot of value if it indeed works as a Shigella vaccine.
I also agree with Whittpa that Big Pharma will want to do a deal. What we don't know are management's expectations of what is fair. We also don't know if they are looking for a straight buyout or a partnership. Regardless, the company burns very little cash and, with NIH paying for the ASH and PNAFLD trials, we have over a year's worth of cash at least so Immuron won't be diluting anytime soon.
In six to eight months, the landscape will look very different with 3 more Phase 2 trial results in (ASH, NAFLD, C.DIFF). Remember, Tobira for example sold for $1.7B when it was trading at an $85M market cap. We don't know what management's expectations are. Maybe as we speak today they would turn down say a $200M USD offer for the company because they think it's far too low. That's a distinct possibility.
Only time will tell. Happy to wait and see this through
- Forums
- ASX - By Stock
- IMC
- Big Pharma Partnership
Big Pharma Partnership, page-21
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
-0.002(2.02%) |
Mkt cap ! $22.11M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.7¢ | $10.38K | 105K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 20229 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.097 |
1 | 51371 | 0.096 |
2 | 114250 | 0.095 |
1 | 100000 | 0.094 |
2 | 91731 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 20229 | 1 |
0.100 | 157482 | 3 |
0.105 | 295769 | 3 |
0.110 | 96204 | 3 |
0.120 | 138000 | 3 |
Last trade - 13.42pm 18/09/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |